People in the News

Premium

Alan Gewirtz, professor of hematology/oncology at the University of Pennsylvania and antisense researcher, died last month.

According to the Philadelphia Inquirer, Gewirtz died of lung cancer.

He was born in New York City, and received an AB in marine biology from Colgate University in 1971 and an MD from the State University of New York at Buffalo in 1976. He joined Penn in 1990, and became a member of the school's Institute for Human Gene Therapy in 1993.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.

Sep
12
Sponsored by
PerkinElmer

This webinar will cover recent advances in the use of CRISPR for generating animal models and cell lines.